Get the Stockscreener App
57.68
1.57%
-0.92
After Hours:
57.50
-0.18
-0.31%
Corcept Therapeutics Inc Stock (CORT) Latest News
Corcept (CORT) Up 19.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Algert Global LLC Increases Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics' chief accounting officer sells $80,031 in stock - Investing.com India
Gary Charles Robb Takes Money Off The Table, Sells $146K In Corcept Therapeutics Stock - Benzinga
Corcept Therapeutics: A Most Promising And Compelling Biotech (NASDAQ:CORT) - Seeking Alpha
Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Purchased by Natixis Advisors LLC - Defense World
StockNews.com Downgrades Corcept Therapeutics (NASDAQ:CORT) to Buy - Defense World
Corcept Therapeutics' chief accounting officer sells $80,031 in stock By Investing.com - Investing.com Australia
Corcept therapeutics executive sells $146,625 in stock - Investing.com
Corcept therapeutics executive sells $146,625 in stock By Investing.com - Investing.com UK
Why Corcept Therapeutics (CORT) is a Top Momentum Stock for the Long-Term - MSN
Alpha DNA Investment Management LLC Invests $464,000 in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Cerity Partners LLC Trims Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Victory Capital Management Inc. Grows Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Zacks Research Has Bullish Forecast for CORT FY2024 Earnings - MarketBeat
Corcept Shares Rise More Than 60% in Three Months: Here's Why - MSN
Corcept Shares Rise More Than 60% In Three Months: Here's Why - Barchart
Q4 EPS Forecast for Corcept Therapeutics Lifted by Analyst - MarketBeat
Wall Street Analysts Think Corcept (CORT) Could Surge 37.91%: Read This Before Placing a Bet - MSN
3 Reasons Growth Investors Will Love Corcept (CORT) - Yahoo Finance
Empowered Funds LLC Buys Shares of 38,541 Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy? - MSN
Connor Clark & Lunn Investment Management Ltd. Raises Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Cornercap Investment Counsel Inc. - MarketBeat
Royce & Associates LP Has $16.81 Million Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Teva Defends Mifepristone Antitrust Case Against Corcept - Law360
Intellectus Partners LLC Purchases Shares of 54,859 Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives $65.25 Average Target Price from Analysts - Defense World
Corcept Therapeutics director Daniel Swisher sells $131,736 in stock By Investing.com - Investing.com Australia
Principal Financial Group Inc. Sells 20,770 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics director Daniel Swisher sells $131,736 in stock - Investing.com
Corcept (CORT) Upgraded to Strong Buy: Here's Why - MSN
Cushing's Syndrome Market to Show a Rise During the Study Period | - openPR
Cushing's Syndrome Market Will Drive an Exponential CAGR - openPR
Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
24,800 Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) Acquired by Versor Investments LP - MarketBeat
Wealth Enhancement Advisory Services LLC Takes $238,000 Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Lisanti Capital Growth LLC Increases Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar And Theravance - Barchart
Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance - Yahoo Finance
CWA Asset Management Group LLC Acquires Shares of 20,800 Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Robeco Institutional Asset Management B.V. Trims Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Stock Price Up 8.9%Time to Buy? - MarketBeat
US Bancorp DE Purchases 12,177 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
M&G Plc Buys New Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics Incorporated (CORT) Soars to 52-Week High, Time to Cash Out? - MSN
New York State Teachers Retirement System Sells 17,222 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics' chief development officer sells $489,700 in stock - Investing.com India
Corcept Therapeutics' chief development officer sells $489,700 in stock By Investing.com - Investing.com UK
Here is Why Growth Investors Should Buy Corcept (CORT) Now - Yahoo Finance
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):